FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics, namely to the application of a probiotic of the species Lactobacillus rhamnosus in preparing a composition for normalising a patient's pathological lipid profile, wherein the above profile comprises lysophospholipid and/or ceramide sphingolipid. A method for normalising the patient's pathological lipid profile by administering the probiotic of the species Lactobacillus rhamnosus in an amount sufficient to achieve the desired effect, into the patient.
EFFECT: using the probiotic of the species Lactobacillus rhamnosus as a part of the composition enables normalising the patient's pathological lipid profile comprising lysophospholipid and/or ceramide sphingolipid.
12 cl, 2 tbl, 4 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL PEPTIDES AND METHODS FOR PRODUCTION THEREOF | 2010 |
|
RU2583579C2 |
| USING LACTOBACILLUS PARACASEI CNCM I-2116 TO TREAT IRRITABLE BOWEL SYNDROME | 2003 |
|
RU2490325C2 |
| MICROORGANISM COMPOSITION (VARIANTS) | 2002 |
|
RU2291899C2 |
| PROBIOTIC COMPOSITION FOR APPLICATION IN TREATMENT OF INTESTINAL INFLAMMATION | 2011 |
|
RU2563525C2 |
| PROBIOTICS FOR INTESTINE NEUROMUSCULAR FUNCTION | 2003 |
|
RU2346036C2 |
| FOODSTUFF | 2004 |
|
RU2282995C2 |
| PROBIOTIC IN PRE- AND/OR POSTOPERATIVE PERIOD | 2008 |
|
RU2470652C2 |
| PROBIOTIC COMPOSITION CONTAINING STRAINS OF LACTOBACILLUS RHAMNOSUS AND LACTOBACILLUS PARACASEI | 2016 |
|
RU2744271C2 |
| UNFERMENTED COMPOSITIONS CONTAINING CEREAL FRACTION AND PROBIOTIC, AND USING THEM | 2010 |
|
RU2580040C2 |
| METHOD FOR RELIEVING ABDOMINAL MURMUR BY INTRODUCING BACTERIA OF GENUS Bifidobacterium | 2009 |
|
RU2492869C2 |
